摘要
背景:人们普遍认为慢性炎症对癌症有重要的促进作用。癌症的免疫耐受介导肿瘤逃离免疫系统。炎症与免疫耐受关系的机制尚不完全阐明。 目的:本文考虑到炎症和耐受的主要机制,讨论了用于干预癌症炎症的药物靶点。 结论:炎症介导肿瘤诱导耐受。慢性炎症反应的诱导和维持是免疫耐受的普遍机制。
关键词: 炎症,分辨率,免疫耐受,肿瘤免疫治疗,肿瘤免疫,肿瘤诱导耐受。
图形摘要
Current Cancer Drug Targets
Title:The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Volume: 17 Issue: 4
关键词: 炎症,分辨率,免疫耐受,肿瘤免疫治疗,肿瘤免疫,肿瘤诱导耐受。
摘要: Background: It is widely accepted that chronic inflammation critically contributes to cancer. Immune tolerance in cancer mediates tumor escape from the immune system. The mechanisms of relations between inflammation and immune tolerance are still not fully elucidated.
Objective: The main mechanisms that link inflammation and tolerance are considered. Drug targets that are in use to interfere with inflammation in cancer are discussed. Conclusion: Inflammation mediates tumor-induced tolerance. The induction and the maintenance of the chronic inflammatory response is a universal mechanism of immune tolerance.Export Options
About this article
Cite this article as:
The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer, Current Cancer Drug Targets 2017; 17 (4) . https://dx.doi.org/10.2174/1568009617666170109110816
DOI https://dx.doi.org/10.2174/1568009617666170109110816 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Use of MicroRNAs in Cancer
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Minimal Access Surgery for Infants and Children
Current Pediatric Reviews Past, Present and Future Therapeutics for Cerebellar Ataxias
Current Neuropharmacology Glyoxalase 1 and 2 Enzyme Inhibitory Activity of 6-Sulfamoylsaccharin and Sulfocoumarin Derivates
Letters in Drug Design & Discovery Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: A New Cause of Hypertension
Current Hypertension Reviews Molecular Response to Hypericin-Induced Photodamage
Current Medicinal Chemistry Cadmium and Its Epigenetic Effects
Current Medicinal Chemistry The Human Indoleamine 2,3-Dioxygenase Gene and Related Human Genes
Current Drug Metabolism The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation
Current Pharmaceutical Biotechnology Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Current Hypertension Reviews Progresses in TCM Metal-Based Antitumour Agents
Anti-Cancer Agents in Medicinal Chemistry Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance
Current Pharmaceutical Design Anti Cancer Activity on Graviola, an Exciting Medicinal Plant Extract vs Various Cancer Cell Lines and a Detailed Computational Study on its Potent Anti-Cancerous Leads
Current Topics in Medicinal Chemistry Development of Cisplatin Nanoparticles as Dry Powder Inhalers for Lung Cancer
Current Nanoscience Ectopic Thyroid Gland: Description of a Case and Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer
Current Medicinal Chemistry Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Current Drug Targets The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design PET Imaging of Multidrug Resistance in Tumors Using 18F-Fluoropaclitaxel
Current Topics in Medicinal Chemistry